CompletedPhase 2NCT00584454
Safety Evaluation of a Q-fever Vaccine, NDBR 105
Studying Q fever
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- U.S. Army Medical Research and Development Command
- Principal Investigator
- Mark Goldberg, MDUSAMRIID Medical Division
- Intervention
- Q Fever Vaccine (NDBR 105(biological)
- Enrollment
- 10 enrolled
- Eligibility
- 17-65 years · All sexes
- Timeline
- 2006 – 2014
Study locations (1)
- U.S. Army Medical Research Institute of Infectious Diseases, Fort Deterick, Maryland, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00584454 on ClinicalTrials.gov